From: CHD1L: a novel oncogene
Tumor origin | Chr1q/CHD1L | Technique used | Biological/clinical impact | References |
---|---|---|---|---|
Breast | Chr1q ( 67%) | CGH | genetic aberration | [6] |
Bladder | Chr1q ( 54%) | CGH | Invasive cancer | [5] |
CHD1L | PCR | Poor prognosis | [31] | |
Chr1q21-24 | CGH + expression | Survival genes | [26] | |
Colorectal | CHD1L | FISH, PCR | Oncogene, Poor survival | [11] |
Esophageal | Chr1q | CGH | Genetic aberration | [9] |
Fibrosarcoma | CHD1L | CGH | Genetic defect | [10] |
Liver | Chr1q21 | CGH | Poor prognosis | [8] |
( 56 ~78%) | FISH | CHD1L was | [12] | |
Chr1q21 | TMA + IHC | Sequenced | [29] | |
CHD1L | Poor prognosis | |||
CHD1L | ||||
Ovarian | CHD1L | TMA + IHC | Metastatic cancer with poor prognosis | [30] |